conference - biotechnology innovation organization 2018 event...investors, industry analysts, and...

bio.org/CEO • #BIOCEO18Event & Sponsorship Prospectus

CE NVESTORCONFERENCE

February 12-13, 2018 • New York Marriott Marquis

CE NVESTORCONFERENCEFebruary 12-13, 2018New York Marriott Marquis

Therapeutic Focus

Attendees: 1,400+

Countries Represented: 28

BIO One-on-One Meetings: 2,600+

Registered Investors: 650

Company Presentations: 190

Expert Speakers: 58

All Others 1%Institute, Hospital Research 1%Digital Health 1%Patient Advocacy 1%

IT, Information 1%Other R&D Services 2%

Investment Bank 2%Academic, Tech Transfer 2%

CMO, CRO 2%Biotech or Pharma, Animal Health 2%

Synthesis, Analytic, Diagnostic Services 3%

Financial, Legal, Consulting 5%

Public, NPO, Govt., Economic Development 6%

Medical Device or Technology 6%

Other Products or Services 7%

Biotech or pharma, therapeutic R&D 58%

Company Types

< 50M

$100M-250M

$250M-500M

$50M-100M

> $500M

42%

25%

4%

16%

13%

Breakdown by Market Cap

C-LEVEL VP OTHERDIRECTOR62% 15% 14% 9%

Audience Demographics

Now in its 20th year, the BIO CEO & Investor Conference is one of the largest investor conference focused on established and emerging publicly traded and select private biotech companies.

Cardiovascular 4%

Metabolic Diseases 4%

Gastrointestinal 4%

Infectious Diseases 5%

Gene/Cell Therapy 5%

Orphan/Rare Diseases 6%

Diagnostics 7%

CNS/Neurological 9%

Other 26%

Oncology 31%





Event Attributes and Opportunities

■ EXPERIENCE the largest, unbiased forum where institutional investors, industry analysts, and senior biotechnology executives shape the future investment landscape of the industry.

■ HEAR Washington’s perspective on policy and other timely developments affecting the industry.

■ EVALUATE fresh investment opportunities including compatible, complementary, and competitive companies.

■ LEARN about the hottest clinical developments and industry catalysts by attending the conference’s therapeutic workshops and business roundtables.

■ ATTEND fireside chats with CEOs who will share their recent company successes, what keeps the C-suite up at night, and where the industry’s leading companies are headed in 2018.

■ GAIN ACCESS to BIO One-on-One Partnering™ for scouting potential investments and deal partners, optimizing your time at the event.

■ UNIQUE PLATFORM for your company to highlight accomplishments and discuss upcoming milestones. Approximately 190 companies will be chosen based on a selection process evaluating a company’s pipeline and R&D activities.

■ GET THE PULSE of the current and proposed investment trends in biotechnology.

■ NETWORK with peers, investors, and potential partners attending the conference and our exclusive receptions.

Past Fireside Chat Speakers

Giovanni Caforio, MDChief Executive OfficerBristol-Myers Squibb

2017 Advisory CommitteeJohn Chambers, President and Head of Investment Banking, H.C. Wainwright & Co., LLCBarbara J. Dalton, PhD, Vice President, Venture Capital, Pfizer Inc.Linda S. Grais, MD, President and Chief Executive Officer, Ocera Therapeutics, Inc.Brian Hagerty, Senior Director, Head of Healthcare Capital Markets, New York Stock ExchangeNouhad Husseini, Vice President, Business Development, Regeneron Pharmaceuticals, Inc.Michael King, Managing Director and Senior Research Analyst, JMP Securities LLCJonathan Leff, Partner, Deerfield Management; Chairman, Deerfield InstituteMichael Margolis, RPh, Managing Director and Head of Healthcare Investment Banking, ROTH Capital Partners, LLCMichael Mirsky, Managing Director, Investment Banking, H.C. Wainwright & Co., LLCTimothy P. O’Connor, PhD, Executive Vice President, The Rockefeller UniversityJason Park, Principal, Flagship PioneeringSusan Peschin, MHS, President and CEO, Alliance for Aging ResearchDennis J. Purcell, Founder and Senior Advisor, Aisling CapitalCarlo Rizzuto, PhD, Partner, Versant VenturesMatthew Roden, PhD, Vice President and Head of Strategic Corporate Development, Bristol-Myers SquibbStephen Sands, Vice Chairman Investment Banking and Chairman Global Healthcare Group, LazardRajeev Shah, Managing Director & Portfolio Manager, RA Capital ManagementNathan Tinker, PhD, Executive Director, NewYorkBIO

Tony Coles, MDChairman and Chief Executive OfficerYumanity Therapeutics

J. Joseph Kim, PhDPresident and Chief Executive OfficerInovio Pharmaceuticals

Jeffrey D. MarrazzoCo-Founder and Chief Executive OfficerSpark Therapeutics

Lynn Seely, MDChief Executive OfficerMyovant Sciences




2017 Sponsors

Supporting Bank Sponsors

Local Co-Host Regional Sponsors

Conference Sponsors

Double Helix Sponsors Helix Sponsor

conference - biotechnology innovation organization 2018 event...investors, industry analysts, and...

Documents